Latest On Bausch Health Companies Inc (BHC):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 17:55 EST | News | Bausch Health rise continues; up another 9% | N/A |  |
| 2023-05-17 14:47 EST | News | Bausch Health soars amid skinny label court decision vs Norwich over Xifaxan drug (update) | N/A | |
| 2023-05-10 13:30 EST | News | Bausch Health: Bullish On Long-Term Prospects, Awaiting Subsiding Headwinds | N/A | |
| 2023-05-09 10:15 EST | News | Bausch Health: There's Still Uncertainty | N/A | |
| 2023-05-04 22:54 EST | News | Bausch Health stock falls ~15% as Q1 net loss widens amid revenue miss | N/A | |
About Bausch Health Companies Inc (BHC):
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the Unite read more...d States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
General
- Name Bausch Health Companies Inc
- Symbol BHC
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 21,600
- Last Split Factor2:1
- Last Split Date2000-10-16
- Fiscal Year EndDecember
- IPO Date1994-03-29
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.bauschhealth.com
Valuation
- Forward PE 6.81
- Price/Sales (Trailing 12 Mt.) 1.47
- Price/Book (Most Recent Quarter) 22.14
- Enterprise Value Revenue 4.38
- Enterprise Value EBITDA 14.49
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $4.48
- Next Year EPS Estimate $5.02
- Next Quarter EPS Estimate $0.96
- Profit Margin -7%
- Operating Margin 17%
- Return on Assets 3%
- Return on Equity -64%
- Revenue 8.03 billion
- Earnings Per Share -$2.61
- Revenue Per Share $22.61
- Gross Profit 5.78 billion
- Quarterly Earnings Growth -0.5%
Highlights
- Market Capitalization 11.66 billion
- EBITDA 3.16 billion
- PE Ratio -4.55
- Analyst Target Price $35.44
- Book Value Per Share $1.51
Share Statistics
- Shares Outstanding 354.99 million
- Shares Float 309.34 million
- % Held by Insiders 56%
- % Held by Institutions 66.76%
- Shares Short 13.49 million
- Shares Short Prior Month 14.61 million
- Short Ratio 2.85
- Short % of Float 4%
- Short % of Shares Outstanding 4%
Technicals
- Beta 1.4
- 52 Week High $34.8
- 52 Week Low $12.49
- 50 Day Moving Average 30.69
- 200 Day Moving Average 22.04
Dividends
- Dividend Date N/A
- ExDividend Date 2010-11-10
- Dividend Yield 0%
ESG Rating
Bausch Health Companies Inc (BHC) Dividend Calendar:
Bausch Health Companies Inc (BHC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Bausch Health Companies Inc (BHC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Bausch Health Companies Inc (BHC) Chart:
Bausch Health Companies Inc (BHC) News:
Below you will find a list of latest news for Bausch Health Companies Inc (BHC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Bausch Health Companies Inc (BHC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest BHC Trades:
Bausch Health Companies Inc (BHC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-03 | 8-K (Current report) | |
| 2020-11-03 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-10-08 | 8-K (Current report) | |
| 2020-10-06 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-10 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-06 | 8-K (Current report) | |
| 2020-08-06 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-07-27 | SC 13D (General statement of acquisition of beneficial ownership) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
Bausch Health Companies Inc (BHC) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bausch Health Companies Inc (BHC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 56%
Institutional Ownership: 6676%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | AMY B WECHSLER | Director | Buy | 442.00 | 15.54 | 6,868.68 | 101,171.00 | |
| 2020-09-30 | RUSSEL C ROBERTSON | Director | Buy | 2,413.00 | 15.54 | 37,498.02 | 111,902.00 | |
| 2020-09-30 | SCHUTTER RICHARD U DE | Director | Buy | 2,171.00 | 15.54 | 33,737.34 | 295,600.00 | |
| 2020-09-30 | John Paulson | Director | Buy | 1,930.00 | 15.54 | 29,992.20 | 71,998.00 | |
| 2020-09-08 | William D. Humphries | President, Ortho-Dermatologics | Sell | 5,667.00 | 16.17 | 91,635.39 | 235,035.00 | |
| 2020-08-28 | CHRISTINA ACKERMANN | EVP AND GENERAL COUNSEL | Buy | 28,171.00 | 124,196.00 | | ||
| 2020-06-30 | AMY B WECHSLER | Director | Buy | 375.00 | 18.29 | 6,858.75 | 100,729.00 | |
| 2020-06-30 | RUSSEL C ROBERTSON | Director | Buy | 2,050.00 | 18.29 | 37,494.50 | 109,489.00 | |
| 2020-06-30 | SCHUTTER RICHARD U DE | Director | Buy | 1,750.00 | 18.29 | 32,007.50 | 293,429.00 | |
| 2020-06-30 | John Paulson | Director | Buy | 1,545.00 | 18.29 | 28,258.05 | 70,068.00 | |
| 2020-06-05 | ValueAct Holdings, L.P. | Director | Sell | 948,353.00 | 19.24 | 18,246,311.72 | 0.00 | |
| 2020-06-05 | ValueAct Holdings, L.P. | Director | Buy | 948,353.00 | 19.24 | 18,246,311.72 | 17,931,594.00 | |
| 2020-05-14 | John Paulson | Director | Buy | 348,920.00 | 15.85 | 5,530,382.00 | 24,559,035.00 | |
| 2020-05-14 | John Paulson | Director | Buy | 70,000.00 | 15.65 | 1,095,500.00 | 24,629,035.00 | |
| 2020-05-14 | John Paulson | Director | Buy | 624,900.00 | 15.87 | 9,917,163.00 | 25,253,935.00 | |
| 2020-05-14 | John Paulson | Director | Buy | 585,100.00 | 15.92 | 9,314,792.00 | 25,839,035.00 | |
| 2020-05-13 | John Paulson | Director | Buy | 603,900.00 | 16.32 | 9,855,648.00 | 23,483,971.00 | |
| 2020-05-13 | John Paulson | Director | Buy | 80,300.00 | 16.58 | 1,331,374.00 | 23,564,271.00 | |
| 2020-05-13 | John Paulson | Director | Buy | 645,844.00 | 16.70 | 10,785,594.80 | 24,210,115.00 | |
| 2020-05-12 | John Paulson | Director | Buy | 25,000.00 | 17.30 | 432,500.00 | 20,864,035.00 | |